Tempest Therapeutics, Inc. (TPST)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Tempest Therapeutics, Inc. (TPST)
Go deeper and ask any question about TPST
Company Performance
Current Price
as of Sep 13, 2024$1.45
P/E Ratio
N/A
Market Cap
$36.55M
Description
Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.
Metrics
Overview
- HQBrisbane, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerTPST
- Price$1.45+9.02%
Trading Information
- Market Cap$36.55M
- Float84.05%
- Average Daily Volume (1m)580,306
- Average Daily Volume (3m)3,007,839
- EPS-$1.61
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$9.57M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$9.43M
- EV$38.51M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings